Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
18,933,281
-
Shares change
-
+504,284
-
Total reported value, excl. options
-
$115,491,000
-
Value change
-
+$2,927,862
-
Number of buys
-
23
-
Number of sells
-
16
-
Price
-
$6.10
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2016
As of 31 Dec 2016 GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) had 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,933,281 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, BVF INC/IL, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, Cormorant Asset Management, LLC, and Candriam Luxembourg S.C.A..
This table shows 49 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.